Mechanisms of cancer cell death induction by paclitaxel: an updated review

S Zhao, Y Tang, R Wang, M Najafi - Apoptosis, 2022 - Springer
Chemoresistance of cancer cells is a major problem in treating cancer. Knowledge of how
cancer cells may die or resist cancer drugs is critical to providing certain strategies to …

Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects

M Ashrafizadeh, A Zarrabi, F Hashemi, ER Moghadam… - Life sciences, 2020 - Elsevier
Dealing with cancer is of importance due to enhanced incidence rate of this life-threatening
disorder. Chemotherapy is an ideal candidate in overcoming and eradication of cancer. To …

Curcumin as an enhancer of therapeutic efficiency of chemotherapy drugs in breast cancer

R Farghadani, R Naidu - International Journal of Molecular Sciences, 2022 - mdpi.com
Female breast cancer is the world's most prevalent cancer in 2020. Chemotherapy still
remains a backbone in breast cancer therapy and is crucial in advanced and metastatic …

Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects

Y Hussain, L Islam, H Khan, R Filosa… - Phytotherapy …, 2021 - Wiley Online Library
The efficacy of chemotherapy in cancer therapy is limited due to resistance, treatment
selectivity, and severe adverse effects. Immunotherapy, chemotherapy, targeted therapy …

Curcumin-and piperine-loaded emulsomes as combinational treatment approach enhance the anticancer activity of curcumin on HCT116 colorectal cancer model

ZB Bolat, Z Islek, BN Demir, EN Yilmaz… - … in bioengineering and …, 2020 - frontiersin.org
Combination chemotherapy, administrating two chemotherapeutic agents concurrently,
comes into prominence, as the heterogeneity or the level of the disease necessitates a …

[HTML][HTML] Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind …

T Saghatelyan, A Tananyan, N Janoyan, A Tadevosyan… - Phytomedicine, 2020 - Elsevier
Background: The clinical efficacy of curcumin has not yet been established for the treatment
of cancer, despite a large body of evidence from numerous preclinical studies suggesting …

Curcumin: modulator of key molecular signaling pathways in hormone-independent breast cancer

R Farghadani, R Naidu - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer remains the most commonly diagnosed cancer and the
leading cause of cancer death among females worldwide. It is a highly heterogeneous …

[PDF][PDF] Curcumin and its derivatives: A review of their biological activities

MK Oglah, YF Mustafa, MK Bashir, MH Jasim… - Syst. Rev …, 2020 - researchgate.net
Since the dawn of humankind, natural products have been widely used as a medicine for the
management of a wide range of diseases that affected the human health (1). Natural product …

Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo

C Pi, W Zhao, M Zeng, J Yuan, H Shen, K Li, Z Su… - Drug Delivery, 2022 - Taylor & Francis
The main aim of this study was to improve the therapeutic potential of a paclitaxel (PTX) and
curcumin (CU) combination regimen using solid lipid nanoparticles (SLNs). PTX and CU …

Co-delivery of curcumin and paclitaxel by “core-shell” targeting amphiphilic copolymer to reverse resistance in the treatment of ovarian cancer

MD Zhao, JQ Li, FY Chen, W Dong… - International journal …, 2019 - Taylor & Francis
Background Ovarian cancer is a common malignancy in the female reproductive system with
a high mortality rate. The most important reason is multidrug resistance (MDR) of cancer …